You have 9 free searches left this month | for more free features.

Carcinoma, Non-Small-Cell Lung

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metabolic Response to Food in Advanced Lung Cancer

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Weight loss (%)
  • (no location specified)
Jun 30, 2023

Learn About Dacomitnib in Non-small Cell Lung Cancer Which Has

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Oct 4, 2023

NSCLC Trial (SGN-B6A, docetaxel)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 21, 2023

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Self-administered survey at hospital
    • +2 more
    • (no location specified)
    Oct 3, 2023

    NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Sugemalimab and Chemotherapy
    • Changsha, China
      Hunan Cancer Hospital
    Jul 7, 2023

    Carcinoma, Non-Small Cell Lung Trial in Zhengzhou (BAI combine with DEB-BACE)

    Not yet recruiting
    • Carcinoma, Non-Small Cell Lung
    • BAI combine with DEB-BACE
    • Zhengzhou, Henan, China
      Gang Wu
    Nov 7, 2023

    NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Wuhan, Hubei, China
      Qian Chu
    Aug 18, 2023

    Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      Apr 21, 2023

      NSCLC Trial (KB-GDT-01)

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • KB-GDT-01
      • (no location specified)
      Sep 29, 2023

      Specific Protein Overexpression in Adult Non-Small Cell Lung

      Not yet recruiting
      • Non Small Cell Lung Cancer
        • (no location specified)
        Sep 29, 2023

        TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

        Not yet recruiting
        • Lung Cancer, Non-small Cell
        • Small Cell Lung Cancer
          • (no location specified)
          Nov 16, 2022

          Stage IB Non-small Cell Lung Cancer

          Completed
          • Stage IB Non-Small Cell Lung Carcinoma
            • Shanghai, China
              180 Fenglin Road
            Jul 29, 2023

            QOL After SURGERY and ADJUVANT Treatment

            Not yet recruiting
            • Carcinoma, Non-Small-Cell Lung
            • Quality of Life
            • Questionnaires
            • Salamanca, Spain
              Hospital Clínico Universitario
            Oct 30, 2023

            Circulating Tumor DNA and T Cell Repertoire Predict

            Not yet recruiting
            • Carcinoma, Non-Small-Cell Lung
            • Brain Metastases
            • Whole-brain radiotherapy
            • Wuhan, Hubei, China
              Union hospital
            Feb 12, 2023

            Carcinoma, Non-small-Cell Lung Trial in New York, Fairfax (JNJ-86974680, Cetrelimab, Radiation Therapy)

            Recruiting
            • Carcinoma, Non-small-Cell Lung
            • New York, New York
            • +1 more
            Nov 8, 2023

            NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

            Active, not recruiting
            • Carcinoma, Non-Small-Cell Lung
            • +2 more
            • Saint Louis, Missouri
              Washington University School of Medicine
            Jan 3, 2023

            NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

            Not yet recruiting
            • Non-small Cell Lung Cancer
            • +2 more
            • Nintedanib, gefitinib, erlotinib, afatinib
            • (no location specified)
            Oct 2, 2023

            NSCLC Trial in Chongqing (procedure, drug, radiation)

            Not yet recruiting
            • Carcinoma, Non-Small-Cell Lung
            • bronchial artery interventional therapy
            • +3 more
            • Chongqing, Chongqing, China
              Daping Hospital, Third Military Medical University
            May 27, 2023

            Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

            Not yet recruiting
            • Stage II-IIIB(N2) Non-small Cell Lung Cancer
            • Shanghai, Shanghai, China
              Shanghai Pulmonary Hospital
            Oct 26, 2023

            NSCLC Trial (JDQ443)

            Not yet recruiting
            • NSCLC
            • (no location specified)
            Feb 2, 2023

            Integrative Multi-Omics Testing for Immunotherapy Response in

            Recruiting
            • Lung Cancer
              • Guangzhou, Guangdong, China
                Nanfang hospital
              Jun 29, 2023

              Non Small Cell Lung Cancer Metastatic Trial (MRI)

              Not yet recruiting
              • Non Small Cell Lung Cancer Metastatic
              • MRI
              • (no location specified)
              May 16, 2023

              Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

              Not yet recruiting
              • Colorectal Neoplasms
              • +5 more
              • (no location specified)
              Nov 9, 2023

              Double-dose Furmonertinib in Treatment of Slow

              Not yet recruiting
              • Non Small Cell Lung Cancer
              • +3 more
              • (no location specified)
              Oct 31, 2023